Anti-fibrotic effects of Nintedanib and Pirfenidone on alveolar epithelial cell function in ex-vivo 3D-Lung Tissue Cultures
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2021
- Schlagwort
-
Lungs
Cell physiology
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
-
Königshoff, Melanie
- DOI
-
10.5282/edoc.28885
- URN
-
urn:nbn:de:bvb:19-288851
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Buhl, Lara
- Königshoff, Melanie
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Adhesive anti-fibrotic interfaces on diverse organs
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Adhesive anti-fibrotic interfaces on diverse organs
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Adhesive anti-fibrotic interfaces on diverse organs
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts